Pharmacokinetic (PK) Analysis Services

The contract calls for the performance of pharmacokinetic studies to assess the absorption, distribution, metabolism, and excretion of a liposomal dexamethasone formulation in rodent models, with the flexibility to conduct studies under either Good Laboratory Practice (GLP) or non-GLP conditions. The work is focused on generating data critical to understanding the in vivo behavior of this novel drug delivery system, ensuring that key pharmacokinetic parameters are accurately measured and documented. The studies must be scientifically rigorous and capable of supporting regulatory submissions or further development of the formulation. This subcontract is issued under the NAICS code 541940 for other scientific and technical consulting services, and is managed by the Department of Veterans Affairs through the 245-NETWORK Contract Office 5. The place of performance is specified as ZIP code 21218, indicating the work will occur in the Baltimore, Maryland area. Solicitations for this opportunity were posted on July 16, 2026, with a response deadline of July 31, 2026, limiting the timeframe for interested parties to submit proposals. While no specific set-aside classification or point of contact is provided, the contract is open for subcontractor bids seeking to fulfill the required preclinical pharmacokinetic testing services.